Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Selects Immuno-Oncology Clinical Candidate CB-1158, an Oral Arginase Inhibitor for the Treatment of Cancer
June 23, 2015 07:00 ET | Calithera Biosciences, Inc.
Similar mechanism of action to IDO inhibitors Potential to combine with anti-CTLA-4, anti-PD-1 and other immuno-oncology therapies SOUTH SAN FRANCISCO, Calif., June 23, 2015 (GLOBE NEWSWIRE) --...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the JMP Securities Life Sciences Conference 2015
June 16, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports Phase I Data for CB-839 in Patients With Acute Leukemias at the 20th Congress of the European Hematology Association
June 11, 2015 16:05 ET | Calithera Biosciences, Inc.
Promising Clinical Activity With Early Signs of Biologic Activity, Tolerability, and Durability Clinical Response Reported With Single Agent CRi in AML SOUTH SAN FRANCISCO, Calif., June 11, 2015...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Reports Phase I Data for CB-839 in Patients with Solid Tumors at the 2015 American Society of Clinical Oncology
May 30, 2015 08:00 ET | Calithera Biosciences, Inc.
Data Support Initiation of Multiple Solid Tumor Expansion Cohorts Calithera to Host Investor Webcast on May 30, 2015 at 6:30 p.m. CT SOUTH SAN FRANCISCO, Calif., May 30, 2015 (GLOBE...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Reports Initial Phase I Data for CB-839 in Patients with Acute Leukemias
May 21, 2015 07:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 21, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics,...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports First Quarter 2015 Financial Results and Recent Highlights
May 07, 2015 16:05 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference - Revised Date of Presentation
May 07, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference
May 06, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Report First Quarter 2015 Financial Results on Thursday, May 7, 2015
April 30, 2015 16:30 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Announces Clinical Data Presentation at ASCO 2015
April 22, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...